Back

Liquid oncocytology: the guardian of women's health

The 21st century has been marked by improvements in the fight against cancer. Preventive screening has become a part of our life norm, which allows us to detect the disease at an early stage and start treatment in time. Uterine cervix cancer (UCC) is a disease that can be prevented if a woman takes responsibility for her own health and does not run away from the cancer screening programme. For example, women from the age of 20 are advised to have a cervical smear every 5 years to detect precancerous cells, which later develop into cancer if not treated. The method has proved its effectiveness, significantly reducing the number of cases of "neglected" cancer. But modern medicine does not stop at what has been achieved: in developed countries, the standard smear is being replaced by more effective examination - liquid oncocytology, which has finally become available for women in Kazakhstan!

And so, the fundamental difference of liquid oncocytology - the maximum reduction in the probability of false negative results, that is, the risk that external factors can "hide" altered cells is reduced.

The routine method has a number of disadvantages, liquid oncocytology corrects these disadvantages! The most important "minus" of the routine method is the appearance of the smear under the microscope: an amorphous mass of cells with an admixture of mucus and blood elements. Thanks to the new method, the biomaterial is not examined under a microscope: a high-precision image of a single layer of cervical cells without blood and mucus is displayed on the monitor!

UTERINE CERVIX CANCER IN FIGURES

4th most common cause of death in women

2nd most common cause of death after breast cancer in the Republic of Kazakhstan.

70% of UCC cases occur in developing countries

50% of UCC cases develop between 35-54 years of age

1/10 of patients with breast cancer are under 30 years of age.

15 years from precancerous cells to UCC

2 women die every day from UCC in the Republic of Kazakhstan

Conventional method	Liquid oncocytology

Manual creation of biomaterial for microscopy (human factor)	Automatic biomaterial creation (no human factor)
About 80 per cent of cells* do not make it to the learning stage	Virtually 100% of the biomaterial is available for study
Cell adhesion and layering	Uniform distribution of cells
Material contaminated with non-cellular biological elements (mucus)	Minimise unnecessary biomaterial
High probability of false negatives	Minimum probability of false negatives
* Hutchinson ML, et al. Homogeneous sampling accounts for the increased diagnotstic accuracy using the ThinPrep® Processor, Am J Clin Pathol. 1994;101:215-19.	Ability to detect cells affected by human papillomavirus (HPV)

In OLYMP CDL, the examination is done on an automatic system EASYPREP ®, which eliminates the possibility of errors associated with the process of creating a preparation for microscopy. The device independently prepares the material for microscopy and displays the image on the monitor.

Thus, liquid oncocytology in OLYMP CDL is a new, maximally effective test, which confidently stands on the guard of women's health!

Attention: the analysis is available in the treatment rooms of OLYMP CDL, where gynaecological smears are taken. Details on the website www.kdlolymp.kz.